Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Larocca

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Current Hematologic Malignancy Reports|April 4, 2016
Nuances in the Management of Older People With Multiple MyelomaCharlotte Pawlyn, Francesca Gay, Alessandra Larocca, et al.
Cancers|June 22, 2023
New Strategies for the Treatment of Older Myeloma PatientsAlessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, et al.
International Journal of Molecular Sciences|December 23, 2022
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Clinical Hematology International|October 1, 2021
Moving Toward Continuous Therapy in Multiple MyelomaFrancesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Oncotarget|September 27, 2017
Emerging drugs and combinations to treat multiple myelomaAlessandra Larocca, Roberto Mina, Francesca Gay, et al.
Expert Review of Hematology|May 16, 2017
How is patient care for multiple myeloma advancing?Sonja Genadieva Stavric, Francesca Bonello, Sara Bringhen, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 14, 2017
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myelomaMarco Salvini, Rossella Troia, Davide Giudice, et al.
Frontiers in Oncology|November 28, 2025
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomibGiuseppe Bertuglia, Mattia Verardo, Matilde Scaldaferri, et al.
Expert Opinion on Pharmacotherapy|June 30, 2017
Melphalan hydrochloride for the treatment of multiple myelomaFabrizio Esma, Marco Salvini, Rossella Troia, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Current Hematologic Malignancy Reports|April 4, 2016
Nuances in the Management of Older People With Multiple MyelomaCharlotte Pawlyn, Francesca Gay, Alessandra Larocca, et al.
Cancers|June 22, 2023
New Strategies for the Treatment of Older Myeloma PatientsAlessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, et al.
International Journal of Molecular Sciences|December 23, 2022
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Clinical Hematology International|October 1, 2021
Moving Toward Continuous Therapy in Multiple MyelomaFrancesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Oncotarget|September 27, 2017
Emerging drugs and combinations to treat multiple myelomaAlessandra Larocca, Roberto Mina, Francesca Gay, et al.
Expert Review of Hematology|May 16, 2017
How is patient care for multiple myeloma advancing?Sonja Genadieva Stavric, Francesca Bonello, Sara Bringhen, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 14, 2017
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myelomaMarco Salvini, Rossella Troia, Davide Giudice, et al.
Frontiers in Oncology|November 28, 2025
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomibGiuseppe Bertuglia, Mattia Verardo, Matilde Scaldaferri, et al.
Expert Opinion on Pharmacotherapy|June 30, 2017
Melphalan hydrochloride for the treatment of multiple myelomaFabrizio Esma, Marco Salvini, Rossella Troia, et al.
Pageof 10